William Blair cut their Q1 2025 earnings per share (EPS) estimates for Arcturus Therapeutics in a report issued on Thursday, March 13th. William Blair analyst M. Minter now forecasts that the ...

Biotech companies make some of the best growth stocks. These firms are at the forefront of medical advances such as gene ...

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT – Get Free Report) has received a consensus recommendation of “Buy” from the ...

Arcturus Therapeutics (ARCT) had a challenging fourth quarter, with revenue and earnings falling short of analyst ...

Late on Thursday night and into the early hours of Friday, the full moon turned a beautiful reddish color as it drifted ...

A ‘breakthrough approach’ for AI-powered automated line clearance in pharmaceutical manufacturing has been developed by ...

Early crew members of the voyaging canoe Hokulea have gathered in Hawaii to celebrate the vessel's 50th birthday. The Hokulea ...

Technology has joined forces with industry leaders in machine vision, edge AI silicon and software – Balluff, Synaptics and ...

From malevolent computers to Arcturian shore leave, here are all the callbacks and references we spotted in these short clips ...

If your space is in need of a refresh going into summer, there's a new maximalist design trend for you. Here's how nature ...

Hawaii’s American colonizers once banned the Hawaiian language in schools. Some Native Hawaiians tried to lighten their skin with lye. Many people believed Polynesian voyagers had simply lucked into ...

Meanwhile Arcturus, a San Diego biotech working with messenger RNA (mRNA) therapies said it is working with Duke-NUS Medical School (Duke-NUS) to develop a coronavirus vaccine for Singapore.